The present invention relates to novel processes for the preparation of the compound of formula I (Iclaprim), related to dihydrofolate reductase inhibitors
and to valuable intermediates of these processes.
本发明涉及制备式I化合物(Iclaprim)的新型工艺,与二氢叶酸还原酶
抑制剂相关,并涉及这些工艺的有价值的中间体。